157 related articles for article (PubMed ID: 2582439)
41. Structure and expression of the beta-platelet-derived growth factor receptor gene in human tumor cell lines.
Malik R; Gope M; Womer RB; Nagashunmugam T; Margolin JF; Basu A; Scher CD
Cancer Res; 1991 Oct; 51(20):5626-31. PubMed ID: 1680555
[TBL] [Abstract][Full Text] [Related]
42. Expression of the polymorphic human DNA repair gene XRCC1 does not correlate with radiosensitivity in the cells of human head and neck tumor cell lines.
Dunphy EJ; Beckett MA; Thompson LH; Weichselbaum RR
Radiat Res; 1992 May; 130(2):166-70. PubMed ID: 1574572
[TBL] [Abstract][Full Text] [Related]
43. Epidermal growth factor receptor gene expression in normal human kidney and renal cell carcinoma.
Sargent ER; Gomella LG; Belldegrun A; Linehan WM; Kasid A
J Urol; 1989 Nov; 142(5):1364-8. PubMed ID: 2810532
[TBL] [Abstract][Full Text] [Related]
44. EGF and TGF-alpha, the ligands of hyperproduced EGFR in human esophageal carcinoma cells, act as autocrine growth factors.
Yoshida K; Kyo E; Tsuda T; Tsujino T; Ito M; Niimoto M; Tahara E
Int J Cancer; 1990 Jan; 45(1):131-5. PubMed ID: 2298497
[TBL] [Abstract][Full Text] [Related]
45. Co-localization of transforming growth factor beta 2 with alpha 1(I) procollagen mRNA in tissue sections of patients with systemic sclerosis.
Kulozik M; Hogg A; Lankat-Buttgereit B; Krieg T
J Clin Invest; 1990 Sep; 86(3):917-22. PubMed ID: 1697606
[TBL] [Abstract][Full Text] [Related]
46. Localization of transforming growth factor-alpha in adult Syrian hamster tissues.
Chou MY; Chou MC; McBride J; Gallagher GT; Matossian K; Elovic A; Wong DT
Lymphokine Cytokine Res; 1991 Oct; 10(5):385-90. PubMed ID: 1768741
[TBL] [Abstract][Full Text] [Related]
47. Expression of mRNA for transforming growth factors-alpha and -beta and secretion of transforming growth factor-beta by renal cell carcinoma cell lines.
Sargent ER; Gomella LG; Wade TP; Ewing MW; Kasid A; Linehan WM
Cancer Commun; 1989; 1(5):317-22. PubMed ID: 2488683
[TBL] [Abstract][Full Text] [Related]
48. Identification of an acidic fibroblast growth factor-like activity in a mesoblastic nephroma.
Witte DP; Nagasaki T; Stambrook P; Lieberman MA
Lab Invest; 1989 Mar; 60(3):353-9. PubMed ID: 2538677
[TBL] [Abstract][Full Text] [Related]
49. Transforming growth factor beta 1, interleukin-8 and interleukin-1, in non-small-cell lung tumors.
Colasante A; Mascetra N; Brunetti M; Lattanzio G; Diodoro M; Caltagirone S; Musiani P; Aiello FB
Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):968-73. PubMed ID: 9310021
[TBL] [Abstract][Full Text] [Related]
50. Distribution of the folate receptor GP38 in normal and malignant cell lines and tissues.
Weitman SD; Lark RH; Coney LR; Fort DW; Frasca V; Zurawski VR; Kamen BA
Cancer Res; 1992 Jun; 52(12):3396-401. PubMed ID: 1596899
[TBL] [Abstract][Full Text] [Related]
51. [Fluorocytophotometic DNA studies in kidney carcinoma].
Vogel J; Schmitz C; Födisch HJ; Jaeger N; Molitor D
Verh Dtsch Ges Pathol; 1989; 73():405-8. PubMed ID: 2482627
[TBL] [Abstract][Full Text] [Related]
52. Human chorionic gonadotropin expression in lung, breast, and renal carcinomas.
Kuida CA; Braunstein GD; Shintaku P; Said JW
Arch Pathol Lab Med; 1988 Mar; 112(3):282-5. PubMed ID: 2449877
[TBL] [Abstract][Full Text] [Related]
53. The expression of C-jun and junB mRNA in renal cell cancer and in vitro regulation by transforming growth factor beta 1 and tumor necrosis factor alpha 1.
Koo AS; Chiu R; Soong J; Dekernion JB; Belldegrun A
J Urol; 1992 Oct; 148(4):1314-8. PubMed ID: 1404666
[TBL] [Abstract][Full Text] [Related]
54. In vivo regulation of transforming growth factor beta 1 transcription by immunotherapy: interleukin-2 impairs interferon-alpha-stimulated increase in steady-state mRNA levels of transforming growth factor beta 1.
Jahn B; Brieger J; Fenchel K; Mitrou PS; Bergmann L
Cancer Immunol Immunother; 1994 May; 38(5):304-10. PubMed ID: 8162612
[TBL] [Abstract][Full Text] [Related]
55. Acquired TGF beta 1 sensitivity and TGF beta 1 expression in cell lines established from a single small cell lung cancer patient during clinical progression.
Nørgaard P; Damstrup L; Rygaard K; Spang-Thomsen M; Poulsen HS
Lung Cancer; 1996 Feb; 14(1):63-73. PubMed ID: 8696721
[TBL] [Abstract][Full Text] [Related]
56. mRNA expression of transforming growth factor alpha in human breast carcinomas and its activity in effusions of breast cancer patients.
Ciardiello F; Kim N; Liscia DS; Bianco C; Lidereau R; Merlo G; Callahan R; Greiner J; Szpak C; Kidwell W
J Natl Cancer Inst; 1989 Aug; 81(15):1165-71. PubMed ID: 2545892
[TBL] [Abstract][Full Text] [Related]
57. Amplification and overexpression of the epidermal growth factor receptor gene in human renal-cell carcinoma.
Ishikawa J; Maeda S; Umezu K; Sugiyama T; Kamidono S
Int J Cancer; 1990 Jun; 45(6):1018-21. PubMed ID: 2351482
[TBL] [Abstract][Full Text] [Related]
58. A novel low molecular weight ribonucleic acid (RNA) related to transforming growth factor alpha messenger RNA.
Jakowlew SB; Kondaiah P; Dillard PJ; Sporn MB; Roberts AB
Mol Endocrinol; 1988 Nov; 2(11):1056-63. PubMed ID: 2464748
[TBL] [Abstract][Full Text] [Related]
59. Transforming growth factor-beta inhibits the growth of renal cell carcinoma in vitro.
Gomella LG; Sargent ER; Linehan WM; Kasid A
J Urol; 1989 May; 141(5):1240-4. PubMed ID: 2540353
[TBL] [Abstract][Full Text] [Related]
60. Transcripts for transforming growth factors in human breast cancer: clinical correlates.
Barrett-Lee P; Travers M; Luqmani Y; Coombes RC
Br J Cancer; 1990 Apr; 61(4):612-7. PubMed ID: 2331446
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
